106 related articles for article (PubMed ID: 30576705)
1. Ligustilide inhibits the activation of cancer-associated fibroblasts.
Ma J; Xu Y; Zheng Q; Wang Y; Hu M; Ma F; Long H; Qin Z; Tao N
Life Sci; 2019 Feb; 218():58-64. PubMed ID: 30576705
[TBL] [Abstract][Full Text] [Related]
2. Ligustilide promotes apoptosis of cancer-associated fibroblasts via the TLR4 pathways.
Ma J; Mei J; Lu J; Wang Y; Hu M; Ma F; Long H; Qin Z; Tao N
Food Chem Toxicol; 2020 Jan; 135():110991. PubMed ID: 31765699
[TBL] [Abstract][Full Text] [Related]
3. MPSSS impairs the immunosuppressive function of cancer-associated fibroblasts via the TLR4-NF-κB pathway.
Xu Y; Ma J; Zheng Q; Wang Y; Hu M; Ma F; Qin Z; Lei N; Tao N
Biosci Rep; 2019 May; 39(5):. PubMed ID: 30992392
[TBL] [Abstract][Full Text] [Related]
4. Cinnamaldehyde Treatment of Prostate Cancer-Associated Fibroblasts Prevents Their Inhibitory Effect on T Cells Through Toll-Like Receptor 4.
Mei J; Ma J; Xu Y; Wang Y; Hu M; Ma F; Qin Z; Xue R; Tao N
Drug Des Devel Ther; 2020; 14():3363-3372. PubMed ID: 32884240
[TBL] [Abstract][Full Text] [Related]
5. Ligustilide inhibits the proliferation of human osteoblastoma MG63 cells through the TLR4-ERK pathway.
Zhang B; Wu D; Hu L; Cha X; Liu Y; Li J; Xie B; Li B; Zheng L
Life Sci; 2022 Jan; 288():118993. PubMed ID: 33545202
[TBL] [Abstract][Full Text] [Related]
6. Ligustilide Inhibits Tumor Angiogenesis by Downregulating VEGFA Secretion from Cancer-Associated Fibroblasts in Prostate Cancer via TLR4.
Ma J; Chen X; Chen Y; Tao N; Qin Z
Cancers (Basel); 2022 May; 14(10):. PubMed ID: 35626012
[TBL] [Abstract][Full Text] [Related]
7. Polysaccharides from Polygonatum Inhibit the Proliferation of Prostate Cancer-Associated Fibroblasts.
Han SY; Hu MH; Qi GY; Ma CX; Wang YY; Ma FL; Tao N; Qin ZH
Asian Pac J Cancer Prev; 2016; 17(8):3829-33. PubMed ID: 27644624
[TBL] [Abstract][Full Text] [Related]
8. Influence of mTOR-inhibitors and mycophenolic acid on human cholangiocellular carcinoma and cancer associated fibroblasts.
Heits N; Heinze T; Bernsmeier A; Kerber J; Hauser C; Becker T; Kalthoff H; Egberts JH; Braun F
BMC Cancer; 2016 May; 16():322. PubMed ID: 27206490
[TBL] [Abstract][Full Text] [Related]
9. Polyphyllin I inhibits gastric cancer cell proliferation by downregulating the expression of fibroblast activation protein alpha (FAP) and hepatocyte growth factor (HGF) in cancer-associated fibroblasts.
Dong R; Guo J; Zhang Z; Zhou Y; Hua Y
Biochem Biophys Res Commun; 2018 Mar; 497(4):1129-1134. PubMed ID: 29499193
[TBL] [Abstract][Full Text] [Related]
10. Targeting the cancer-associated fibroblasts as a treatment in triple-negative breast cancer.
Takai K; Le A; Weaver VM; Werb Z
Oncotarget; 2016 Dec; 7(50):82889-82901. PubMed ID: 27756881
[TBL] [Abstract][Full Text] [Related]
11. Activation of mutated TRPA1 ion channel by resveratrol in human prostate cancer associated fibroblasts (CAF).
Vancauwenberghe E; Noyer L; Derouiche S; Lemonnier L; Gosset P; Sadofsky LR; Mariot P; Warnier M; Bokhobza A; Slomianny C; Mauroy B; Bonnal JL; Dewailly E; Delcourt P; Allart L; Desruelles E; Prevarskaya N; Roudbaraki M
Mol Carcinog; 2017 Aug; 56(8):1851-1867. PubMed ID: 28277613
[TBL] [Abstract][Full Text] [Related]
12. Ligustilide inhibits vascular smooth muscle cells proliferation.
Lu Q; Qiu TQ; Yang H
Eur J Pharmacol; 2006 Aug; 542(1-3):136-40. PubMed ID: 16806164
[TBL] [Abstract][Full Text] [Related]
13. Ligustilide Ameliorates Inflammatory Pain and Inhibits TLR4 Upregulation in Spinal Astrocytes Following Complete Freund's Adjuvant Peripheral Injection.
Qian B; Li F; Zhao LX; Dong YL; Gao YJ; Zhang ZJ
Cell Mol Neurobiol; 2016 Jan; 36(1):143-9. PubMed ID: 26115624
[TBL] [Abstract][Full Text] [Related]
14. Ligustilide attenuates vascular inflammation and activates Nrf2/HO-1 induction and, NO synthesis in HUVECs.
Choi ES; Yoon JJ; Han BH; Jeong DH; Lee YJ; Kang DG; Lee HS
Phytomedicine; 2018 Jan; 38():12-23. PubMed ID: 29425644
[TBL] [Abstract][Full Text] [Related]
15. A polysaccharide from Dictyophora indusiata inhibits the immunosuppressive function of cancer-associated fibroblasts.
Han S; Ma C; Hu M; Wang Y; Ma F; Tao N; Qin Z
Cell Biochem Funct; 2017 Oct; 35(7):414-419. PubMed ID: 28990218
[TBL] [Abstract][Full Text] [Related]
16. Cancer-Associated Fibroblasts in Pancreatic Cancer: Should They Be Deleted or Reeducated?
Qu C; Wang Q; Meng Z; Wang P
Integr Cancer Ther; 2018 Dec; 17(4):1016-1019. PubMed ID: 30136592
[TBL] [Abstract][Full Text] [Related]
17. Anti-inflammatory effects of (Z)-ligustilide through suppression of mitogen-activated protein kinases and nuclear factor-κB activation pathways.
Chung JW; Choi RJ; Seo EK; Nam JW; Dong MS; Shin EM; Guo LY; Kim YS
Arch Pharm Res; 2012 Mar; 35(4):723-32. PubMed ID: 22553066
[TBL] [Abstract][Full Text] [Related]
18. Ligustilide prevents the apoptosis effects of tumour necrosis factor-alpha during C2C12 cell differentiation.
Shi Y; Wang D; Lu L; Yin Y; Wang M; Li C; Diao J; Wang Y; Wei L
Int Immunopharmacol; 2014 Apr; 19(2):358-64. PubMed ID: 24560902
[TBL] [Abstract][Full Text] [Related]
19. Ligustilide prevents LPS-induced iNOS expression in RAW 264.7 macrophages by preventing ROS production and down-regulating the MAPK, NF-κB and AP-1 signaling pathways.
Su YW; Chiou WF; Chao SH; Lee MH; Chen CC; Tsai YC
Int Immunopharmacol; 2011 Sep; 11(9):1166-72. PubMed ID: 21457761
[TBL] [Abstract][Full Text] [Related]
20. Klotho upregulation contributes to the neuroprotection of ligustilide against cerebral ischemic injury in mice.
Long FY; Shi MQ; Zhou HJ; Liu DL; Sang N; Du JR
Eur J Pharmacol; 2018 Feb; 820():198-205. PubMed ID: 29233659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
